切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2019, Vol. 13 ›› Issue (02) : 111 -115. doi: 10.3877/cma.j.issn.1674-0785.2019.02.006

所属专题: 文献

临床研究

促黄体生成素基础值<0.1 IU/L的外周性与中枢性性早熟女童的临床特点比较
解淑钰1, 李旗1, 司彩云2, 陶月红2,()   
  1. 1. 116000 大连医科大学
    2. 225001 江苏扬州,扬州大学附属苏北人民医院儿科
  • 收稿日期:2018-11-07 出版日期:2019-01-15
  • 通信作者: 陶月红

Comparison of clinical characteristics between peripheral and central precocious puberty girls with basal luteinizing hormone less than 0.1 IU/L

Shuyu Xie1, Qi Li1, Caiyun Si2, Yuehong Tao2,()   

  1. 1. Dalian Medical University, Dalian 116000, China
    2. Department of Pediatrics, Subei Hospital, Yangzhou University Clinical Medical College, Yangzhou 225001, China
  • Received:2018-11-07 Published:2019-01-15
  • Corresponding author: Yuehong Tao
  • About author:
    Corresponding author: Tao Yuehong, Email:
引用本文:

解淑钰, 李旗, 司彩云, 陶月红. 促黄体生成素基础值<0.1 IU/L的外周性与中枢性性早熟女童的临床特点比较[J]. 中华临床医师杂志(电子版), 2019, 13(02): 111-115.

Shuyu Xie, Qi Li, Caiyun Si, Yuehong Tao. Comparison of clinical characteristics between peripheral and central precocious puberty girls with basal luteinizing hormone less than 0.1 IU/L[J]. Chinese Journal of Clinicians(Electronic Edition), 2019, 13(02): 111-115.

目的

分析促黄体生成素(LH)基础值<0.1 IU/L的外周性性早熟(PPP)及中枢性性早熟(CPP)女童的临床特点,以指导临床合理采用促性腺激素释放激素(GnRH)激发试验诊断性早熟。

方法

收集2016年2月至2018年8月在扬州大学临床医学院苏北人民医院儿童性早熟门诊就诊的LH基础值<0.1 IU/L的PPP女童(263例)及CPP女童(20例)为研究对象,比较2组间的临床特点的差异,采用Logistic回归分析进行CPP危险因素的分析,采用受试者工作特征曲线(ROC)评价相关指标对CPP的诊断价值。

结果

PPP组患儿与CPP组患儿在乳房开始发育年龄、就诊年龄、就诊身高、体质量指数、遗传靶身高、生长速率、子宫内膜出现情况、直径>4 mm卵泡所占比例及FSH基础值方面比较的差异均无统计学意义(P>0.05);在骨龄超前[(3.7±9.8)个月 vs (15.3±9.6)个月]、卵巢体积[1.1(0.7,1.7)ml vs 1.8(1.3,2.4)ml]、子宫长度[18(16,20)cm vs 21(16,24)cm]、子宫容积[0.9(0.6,1.4)ml vs 1.3(0.8,2.4)ml]、雌二醇水平[18.4(18.3,25.3)pmol/L vs 33.3(18.4,43.0)pmol/L]、预测身高受损值[(-0.4±7.4)cm vs (5.5±5.7)cm]方面,2组间比较,差异均具有统计学意义(t=-4.908,P<0.001;Z=-3.916,P<0.001;Z=-2.309,P=0.021;Z=-3.227,P=0.001;Z=-3.182,P=0.001;t=1.223,P=0.001)。Logistic回归分析发现骨龄超前(OR=0.844)及子宫容积(OR=0.330)是诊断CPP的2个独立危险因素。骨龄超前及子宫容积对LH基础值<0.1 IU/L时CPP的诊断预测价值的AUC分别为0.830、0.716(P<0.001)。骨龄超前的切割值为11.5个月时对应的约登指数最大(0.629),敏感度为80.0%、特异度为82.9%;子宫容积的切割值为2.085 ml时对应的约登指数最大(0.401),敏感度为45.0%、特异度为95.1%。

结论

LH基础值小于0.1 IU/L的性早熟女童不能完全排除下丘脑-垂体-性腺轴启动,如骨龄超前11.5个月以上或子宫容积大于2.085 ml应做GnRH激发试验以排除CPP可能。

Objective

To compare the clinical characteristics of peripheral precocious puberty (PPP) and central precocious puberty (CPP) girls with a basal luteinizing hormone (LH) level less than 0.1 IU/L to guide the reasonable clinical diagnosis of precocious puberty by the gonadotropin-releasing hormone (GnRH) stimulating test.

Methods

From February 2016 to August 2018, PPP girls (263 cases) and CPP girls (20 cases) with a basal LH value<0.1 IU/L who visited the Subei Hospital of Clinical Medical College of Yangzhou University were studied. Data were compared between groups, and logistic regression analysis was perform to identify the relevant risk factors and ROC curve was used to evaluate the diagnostic value of related indicators.

Results

There were no significant differences between the PPP group and the CPP group in breast development age, age at visit, height at visit, body mass index, genetic target height, growth rate, endometrium appearance, proportion of>4 mm follicles, or basal FSH value. There were significant differences between the two groups in advanced bone age [(3.7±9.8) months vs (15.3±9.6) months, t=-4.908, P<0.001], ovary volume [1.1 (0.7, 1.7) ml vs 1.8 (1.3, 2.4) ml, Z=-3.916, P<0.001], uterine length [18 (16, 20) cm vs 21 (16, 24) cm, Z=-2.309, P=0.021], uterine volume [0.9 (0.6, 1.4) ml vs 1.3 (0.8, 2.4) ml, Z=-3.227, P=0.001], estradiol [18.4 (18.3, 25.3) pmol/L vs 33.3 (18.4, 43.0) pmol/L, Z=-3.182, P=0.001], and predicted compromised adult height (PAH-TH) [(-0.4±7.4) cm vs (5.5±5.7) cm, t=1.223, P=0.001]. Logistic regression analysis demonstrated that the months of advanced bone age (OR=0.844) and uterine volume (OR=0.330) were two independent risk factors for the diagnosis of CPP. ROC curve analysis showed that the area under the curve (AUC) of advanced bone age and uterine volume was 0.830 and 0.716, respectively. When the cutoff value for advanced bone age was 11.5 months, the sensitivity and specificity for diagnosis of CPP were 80.0% and 82.9%, respectively. When the cutoff value for uterine volume was 2.085 mL, the sensitivity and specificity for diagnosis of CPP were 45.0% and 95.1%, respectively.

Conclusion

The hypothalamic-pituitary-gonadal axis (HPGA) activation cannot be completely ruled out if basal LH is less than 0.1 IU/L. In these girls, GnRH stimulation test should be conducted to exclude CPP if the bone age is more than 11.5 months ahead or the uterine volume is greater than 2.085 ml.

表1 LH基础值<0.1 IU/L的2组性早熟女童临床特点比较
图1 骨龄超前及子宫容积对LH基础值<0.1 IU/L的CPP患儿的诊断预测价值
1
中华医学会儿科学分会内分泌遗传代谢学组.中枢性性早熟诊断与治疗共识(2015) [J].中华儿科杂志, 2015, 53(6): 412-418.
2
Carel JC, Eugster EA, Rogol A, et al. Consensus statement on the use of gonadotropin-releasing hormone analogs in children [J]. Pediatrics, 2009, 123(4): e752-e762.
3
杜敏联. 根据G-P图谱测骨龄法预测成年身高表 [M]//杜敏联. 青春期内分泌学. 北京: 人民卫生出版社, 2006: 417-418.
4
欧阳力雪, 杨凡. 基础血清黄体生成素水平对女孩中枢性性早熟诊断价值的探讨 [J]. 中国当代儿科杂志, 2017, 19(7): 729-733.
5
Harrington J, Palmert MR, Hamilton J. Use of local data to enhance uptake of published recommendations: an example from the diagnostic evaluation of precocious puberty [J]. Arch Dis Child, 2014, 99(1): 15-20.
6
Brito VN, Spinola-Castro AM, Kochi C, et al. Central precocious puberty: revisiting the diagnosis and therapeutic management [J]. Arch Endocrinol Metab, 2016, 60(2): 163-172.
7
Klein KO, Dragnic S, Soliman AM, et al. Predictors of bone maturation, growth rate and adult height in children with central precocious puberty treated with depot leuprolide acetate [J]. J Pediatr Endocrinol Metab, 2018, 31(6): 655-663.
8
唐大川, 罗鸿昌. 盆腔超声对女童中枢性性早熟的诊断价值 [J]. 临床超声医学杂志, 2017, 19(2): 105-108.
9
Lee SH, Joo EY, Lee JE, et al. The Diagnostic Value of Pelvic Ultrasound in Girls with Central Precocious Puberty [J]. Chonnam Med J, 2016, 52(1): 70-74.
10
Gillis D, Karavani G, Hirsch HJ, et al. Time to menarche and final height after histrelin implant treatment for central precocious puberty [J]. J Pediatr, 2013, 163(2): 532-536.
[1] 袁媛. 多肽类激素kisspeptin的生殖内分泌功能研究进展[J]. 中华妇幼临床医学杂志(电子版), 2016, 12(04): 489-492.
[2] 李春枝, 古建平, 陈永兴, 刘晓景. 知柏地黄丸联合大补阴丸治疗儿童中枢性性早熟56例临床分析[J]. 中华妇幼临床医学杂志(电子版), 2013, 09(04): 504-506.
[3] 王喜平, 徐旭, 蒋莉, 徐露莲, 顾克凤, 刘珍珍, 陆杨. 碳酸钙D3片联合亮丙瑞林对中枢性性早熟女童性激素和骨代谢的影响[J]. 中华临床医师杂志(电子版), 2022, 16(10): 965-969.
[4] 何敏, 黄桢. 加减知柏地黄丸对特发性中枢性性早熟小鼠骨细胞骨形成蛋白-Smads信号通路的影响[J]. 中华临床实验室管理电子杂志, 2023, 11(04): 214-220.
[5] 侯悦, 刘福朋, 张艳红, 张梅, 班博, 赵倩倩, 张红丽, 李艳英. 基础黄体生成素水平对女童中枢性性腺启动状态的预测能力分析[J]. 中华诊断学电子杂志, 2023, 11(02): 109-114.
阅读次数
全文


摘要